Columvi Prices, Coupons, Copay Cards & Patient Assistance
Columvi (glofitamab) is a member of the bispecific T-cell engagers (BiTE) drug class and is commonly used for Diffuse Large B-Cell Lymphoma.
Columvi prices
Intravenous Solution
gxbm 1 mg/mL Columvi intravenous solution from $2,655.34 for 2.5 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 2.5 milliliters | $1,062.14 | $2,655.34 |
| 10 milliliters | $1,059.77 | $10,597.70 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Columvi Coupons, Copay Cards and Rebates
Columvi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Columvi Genentech Oncology Co-pay Assistance Program
Eligible commercially insured patients may pay as little as $0 per treatment with a maximum svings of $25,000 per calendar year.
- Applies to:
- Columvi
- Number of uses:
- Per prescription per calendar year
Form more information phone: 855-692-6729 or Visit website
Columvi Genentech Oncology Co-pay Assistance Program Rebate
Eligible commercially insured patients may submit a rebate request if they paid out-of-pocket for treatment; patient must pay in full for treatment before submitting the rebate request; for additional information contact the program at 855-692-6729.
- Applies to:
- Columvi
- Number of uses:
- One rebate per prescription fill
Form more information phone: 855-692-6729 or Visit website
Patient Assistance & Copay Programs for Columvi
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Genentech Oncology Access Solutions
Eligibility requirements:- Determined case by case
- Based on FPL
- Varies
- Must be treated by US licensed healthcare provider
- Call for most recent medications as the list is subject to change. Eligibility determined on a case-by-case basis. Contact program for details.
- Columvi (glofitamab-gxbm) Injection; IV
More information please phone: 888-249-4918 or 866-422-2377 Visit website
Provider: Genentech Patient Foundation
Eligibility requirements:- Uninsured or Underinsured with no prescription coverage for needed medication
- Based on FPL
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Columvi (glofitamab-gxbm) Injection; IV
More information please phone: 888-941-3331 or 866-422-2377 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Rituxan
Rituxan is used to treat certain leukemias and lymphomas and some non-cancer conditions, such as ...
Monjuvi
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL) in combination with lenalidomide ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Kymriah
Kymriah is used to treat B-cell precursor acute lymphoblastic leukemia (ALL), large B-cell ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma (FL) in adults. It is a p ...
Zynlonta
Zynlonta (loncastuximab tesirine) is used to treat relapsed or refractory diffuse large B-cell ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
More about Columvi (glofitamab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español